Novartis India Ltd Q3 FY2022-23 net profit drops to Rs. 7.61 crores

Novartis India Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 88.53 crores during the period ended December 31, 2022 as compared to Rs. 108.38 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 7.61 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 18.35 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 3.08 for the period ended December 31, 2022 as compared to Rs. 7.43 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹88.53 crs	₹108.38 crs	-18.32%
Net Profit	₹7.61 crs	₹18.35 crs	-58.53%
EPS	₹3.08	₹7.43	-58.55%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.88.53 crores during the period ended December 31, 2022 as compared to Rs.105 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.7.61 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.6.35 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.3.08 for the period ended December 31, 2022 as compared to Rs.2.57 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹88.53 crs	₹105 crs	-15.69%
Net Profit	₹7.61 crs	₹6.35 crs	19.84%
EPS	₹3.08	₹2.57	19.84%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.344.35 crores during the 9 Months period ended December 31, 2022 as compared to Rs.320.43 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.78.34 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.19.65 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.31.74 for the 9 Months period ended December 31, 2022 as compared to Rs.7.96 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹344.35 crs	₹320.43 crs	7.46%
Net Profit	₹78.34 crs	₹19.65 crs	298.68%
EPS	₹31.74	₹7.96	298.74%

Shares of Novartis India Limited was last trading in BSE at Rs. 638.25 as compared to the previous close of Rs. 639.65. The total number of shares traded during the day was 1185 in over 220 trades.

The stock hit an intraday high of Rs. 639.90 and intraday low of 626.00. The net turnover during the day was Rs. 752315.00.

Source : Equity Bulls

Keywords

NovartisIndia Q3FY23 9MFY23 ResultUpdate